Unknown PHASE4 INTERVENTIONAL 2-arm NCT01331902

Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement

Sponsor: Inje University Ilsan Paik Hospital

Conditions Coronary Artery Disease Myocardial Ischemia

Interventions Maximal Hyperemia with Adenosine Followed by Nicorandil Maximal Hyperemia with Nicorandil Followed by Adenosine

Updated 7 times since 2017 Last updated: Apr 7, 2011 Started: Mar 31, 2011 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Artery Disease and Myocardial Ischemia, this trial is ongoing. The trial is conducted by Inje University Ilsan Paik Hospital and has accumulated 7 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Sep 2022 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2021 — Sep 2022 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Inje University Ilsan Paik Hospital
Keimyung University Dongsan Medical Center
Seoul National University Boramae Hospital
Seoul National University Hospital

Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea